198 related articles for article (PubMed ID: 30150278)
21. Ectopic intracranial retinoblastoma in a 3.5-month-old infant without eye involvement and without evidence of heritability.
Römer T; Temming P; Lohmann DR; Sturm D; von Deimling A; Sellhaus B; Mull M; Kontny U; Moser O
Pediatr Blood Cancer; 2019 May; 66(5):e27599. PubMed ID: 30604586
[TBL] [Abstract][Full Text] [Related]
22. Pineoblastoma Without Retinal Tumors in a Patient With a Mosaic Retinoblastoma Pathogenic Variant.
Mustafi D; Waligorski N; Paulson V; Cole B; Crotty EE; Stacey AW
JAMA Ophthalmol; 2022 Apr; 140(4):437-439. PubMed ID: 35297960
[No Abstract] [Full Text] [Related]
23. Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination.
Pascual-Pasto G; Olaciregui NG; Vila-Ubach M; Paco S; Monterrubio C; Rodriguez E; Winter U; Batalla-Vilacis M; Catala J; Salvador H; Parareda A; Schaiquevich P; Suñol M; Mora J; Lavarino C; de Torres C; Chantada GL; Carcaboso AM
Cancer Lett; 2016 Sep; 380(1):10-9. PubMed ID: 27319373
[TBL] [Abstract][Full Text] [Related]
24. Tandem high-dose chemotherapy followed by autologous stem cell transplantation: An infant with trilateral retinoblastoma.
Toret E; Ozdemir ZC; Zengin Ersoy G; Oztunali C; Bozkurt C; Kebudi R
Pediatr Transplant; 2023 Jun; 27(4):e14504. PubMed ID: 36919672
[TBL] [Abstract][Full Text] [Related]
25. Trilateral retinoblastoma: clinical and radiologic progression.
Provenzale JM; Gururangan S; Klintworth G
AJR Am J Roentgenol; 2004 Aug; 183(2):505-11. PubMed ID: 15269048
[TBL] [Abstract][Full Text] [Related]
26. Using RB1 mutations to assess minimal residual disease in metastatic retinoblastoma.
Dimaras H; Rushlow D; Halliday W; Doyle JJ; Babyn P; Abella EM; Williams J; Héon E; Gallie BL; Chan HS
Transl Res; 2010 Aug; 156(2):91-7. PubMed ID: 20627193
[TBL] [Abstract][Full Text] [Related]
27. Trilateral retinoblastoma: a meta-analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma.
Kivelä T
J Clin Oncol; 1999 Jun; 17(6):1829-37. PubMed ID: 10561222
[TBL] [Abstract][Full Text] [Related]
28. Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma).
Shields CL; Meadows AT; Shields JA; Carvalho C; Smith AF
Arch Ophthalmol; 2001 Sep; 119(9):1269-72. PubMed ID: 11545631
[TBL] [Abstract][Full Text] [Related]
29. Asynchronous pineoblastoma is more likely after early diagnosis of retinoblastoma: a meta-analysis.
de Jong MC; Shaikh F; Gallie B; Kors WA; Jansen RW; Dommering C; de Graaf P; Moll AC; Dimaras H; Shroff M; Kivelä TT; Soliman SE
Acta Ophthalmol; 2022 Feb; 100(1):e47-e52. PubMed ID: 33939299
[TBL] [Abstract][Full Text] [Related]
30. Trilateral retinoblastoma--a case report.
Srinivasan US; Pavai A; Sethumadhavan V
Ann Acad Med Singap; 1998 Mar; 27(2):262-4. PubMed ID: 9663322
[TBL] [Abstract][Full Text] [Related]
31. CRX/OTX3: a useful marker in the differential diagnosis of tumors of the pineal region and indicator of photoreceptor differentiation in medulloblastomas and atypical teratoid rhabdoid tumors.
Gielen GH; Gessi M; Denkhaus D; Pietsch T
Appl Immunohistochem Mol Morphol; 2013 May; 21(3):248-53. PubMed ID: 23235340
[TBL] [Abstract][Full Text] [Related]
32. [Trilateral retinoblastoma. Correlation between the genetic anomalies of the RB1 gene and the presence of pineal gland cysts].
Ruiz Del Río N; Abelairas Gómez JM; Alonso García de la Rosa FJ; Peralta Calvo JM; de Las Heras Martín A
Arch Soc Esp Oftalmol; 2014 Jan; 89(1):4-9. PubMed ID: 24269417
[TBL] [Abstract][Full Text] [Related]
33. Lack of correlation between age at diagnosis and RB1 mutations for unilateral retinoblastoma: the importance of genetic testing.
Berry JL; Lewis L; Zolfaghari E; Green S; Le BHA; Lee TC; Murphree AL; Kim JW; Jubran R
Ophthalmic Genet; 2018 Jun; 39(3):407-409. PubMed ID: 29286867
[No Abstract] [Full Text] [Related]
34. [Diagnostic imaging of intraocular lesions in the child].
Balmer A; Munier F; Uffer S
Klin Monbl Augenheilkd; 1998 May; 212(5):252-6. PubMed ID: 9677545
[TBL] [Abstract][Full Text] [Related]
35. Regarding chemoreduction for retinoblastoma and intracranial neoplasms.
Meadows AT; Shields CL
Arch Ophthalmol; 2004 Oct; 122(10):1570-1; author reply 1571. PubMed ID: 15477483
[No Abstract] [Full Text] [Related]
36. Screening for pineoblastoma in patients with retinoblastoma.
Moll AC; Imhof SM; Schouten-Van Meeteren AY; Boers M
Arch Ophthalmol; 2002 Dec; 120(12):1774; author reply 1774. PubMed ID: 12470168
[No Abstract] [Full Text] [Related]
37. Association of a suprasellar mass and intraocular retinoblastoma: a variant of pineal trilateral retinoblastoma?
Bejjani GK; Donahue DJ; Selby D; Cogen PH; Packer R
Pediatr Neurosurg; 1996 Nov; 25(5):269-75. PubMed ID: 9309793
[TBL] [Abstract][Full Text] [Related]
38. Successful treatment of trilateral retinoblastoma with conventional and high-dose chemotherapy plus radiotherapy: a case report.
De Ioris MA; Fidani P; Munier FL; Serra A; Ilari I; Popovic MB; Natali G; Secco DE; Cozza R
J Pediatr Hematol Oncol; 2010 Nov; 32(8):e343-5. PubMed ID: 20881869
[TBL] [Abstract][Full Text] [Related]
39. Trilateral retinoblastoma.
Antoneli CB; Ribeiro Kde C; Sakamoto LH; Chojniak MM; Novaes PE; Arias VE
Pediatr Blood Cancer; 2007 Mar; 48(3):306-10. PubMed ID: 16572402
[TBL] [Abstract][Full Text] [Related]
40. Incidence of pineal gland cyst and pineoblastoma in children with retinoblastoma during the chemoreduction era.
Abramson DH; Dunkel IJ; Marr BP; Francis J; Gobin YP
Am J Ophthalmol; 2013 Dec; 156(6):1319-20. PubMed ID: 24238207
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]